Gossamer Bio Inc
NASDAQ:GOSS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Gossamer Bio Inc
NASDAQ:GOSS
|
US |
|
Premier Graphene Inc
OTC:BIEI
|
US |
|
Macfarlane Group PLC
F:5K6
|
UK |
|
C
|
Cooper-Standard Holdings Inc
SWB:C31
|
US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
US |
|
Csam Health Group AS
F:6Q1
|
NO |
|
Atico Mining Corp
XTSX:ATY
|
CA |
|
J
|
Juniper Networks Inc
F:JNP
|
US |
|
Asustek Computer Inc
OTC:ASUUY
|
TW |
|
R
|
Relx PLC
XHAM:RDEB
|
UK |
|
Zenith Exports Ltd
NSE:ZENITHEXPO
|
IN |
|
MorphoSys AG
NASDAQ:MOR
|
DE |
|
E
|
Endeavour Silver Corp
SWB:EJD
|
CA |
|
Alma Metals Ltd
ASX:ALM
|
AU |
|
W.p. Carey Inc
NYSE:WPC
|
US |
|
Breville Group Ltd
F:HDE
|
AU |
|
Qian Hu Corporation Ltd
SGX:BCV
|
SG |
|
YTL Corporation Bhd
KLSE:YTL
|
MY |
Bankruptcy Probability
Gossamer Bio Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Gossamer Bio Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
67.7m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
459.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
183B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
75.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
44.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Gossamer Bio Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Gossamer Bio Inc has no debt.
You can find a full breakdown on its Balance Sheet.